KOA Medical/Healthcare
Kingdom of Ajerrin Medical & Healthcare Sectors
Marine Biotechnology
The Kingdom of Ajerrin is a global leader of Marine Biotechnology companies, which is the process that involves the marine resources of the world that are studied in biotechnology applications. The applications are utilized in numerous tasks, such as deriving new cancer treatments from marine organisms to localized seaweed farming. Companies focus on hiring professionals that are trained in the disciplines of marine biology, microbiology, chemistry, genomics, bioinformatics, and related fields. Marine biotechnology focuses not only on little known forms of deep ocean life but also on the growing use of marine life in the food, cosmetic and agricultural industries, such as aquaculture.
Ola Marine BioTech is a global leader in microalgae and photobioreactor technology, and owns extensive intellectual property dedicated to the culture of microalgae for biofuels or inflammatory disorders such as eczema, rhinitis, psoriasis, asthma and IBD. XX has also manufactured natural astaxanthin from microalgae for over a decade, providing cosmetic ingredients for the skincare market and nutracel ingredients for the food markets on a global scale.
Pharmaceuticals
Puhi Pharmaceutical is a unique BioPharma company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases in the areas of oncology, cardiovascular, immunoscience and fibrosis. Puhi’s botanical and plant-derived medicines retrieved from rainforests have built a sustainable pipeline of potential therapies and partner with external innovation to broaden and accelerate the needed work, including Omau, an anti-cancer chemotherapy drug. Puhi Pharma’s top selling drugs include the antipsychotic drug Heeia, the Anticoagulant Olina, Lung-cancer chemotherapy drug Hawia, the HIV antiviral drugs Honomu and Makena, and the autoimmune drug Kawela. In December 2017, Puhi Research Division was chosen to be part of a A$25 million research grant for the Savaian Institute of Medicine Research Facility in Hina, Ajerrin.
Medical Technology
Medical Technology company Kryker Corp is a multi-billion Ajerri firm headquartered in Folani Point, Lahui. Kryker’s products include implants used in joint replacement and trauma surgeries, surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, neurosurgical, neurovascular and spinal devices, along with other divides in medical specialties. In November of 2017, Stryker bought Terncan-based Edvards Lifesciences, for A$2.825 billion. Edvards specializes in artificial heart valves and hemodynamic monitoring, which creates the fourth segment of the $A11.8 billion company with more than 40,000 employed across the globe. Most of Kryker’s products are marketed directly to doctors and hospitals in more than 45 countries through company-owned subsidiaries and branches.